J006-2630 Screening compound: 2-(4-{[2-(3-ethyl-1,2-oxazol-5-yl)pyrrolidin-1-yl]methyl}-2-methoxyphenoxy)acetamide

J006-2630 Screening compound: 2-(4-{[2-(3-ethyl-1,2-oxazol-5-yl)pyrrolidin-1-yl]methyl}-2-methoxyphenoxy)acetamide
J006-2630 Screening compound: 2-(4-{[2-(3-ethyl-1,2-oxazol-5-yl)pyrrolidin-1-yl]methyl}-2-methoxyphenoxy)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J006-2630
2-(4-{[2-(3-ethyl-1,2-oxazol-5-yl)pyrrolidin-1-yl]methyl}-2-methoxyphenoxy)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J006-2630

Molecular Formula

C19H25N3O4 (C19 H25 N3 O4)

Compound Name

2-(4-{[2-(3-ethyl-1,2-oxazol-5-yl)pyrrolidin-1-yl]methyl}-2-methoxyphenoxy)acetamide

IUPAC name

2-(4-{[2-(3-ethyl-12-oxazol-5-yl)pyrrolidin-1-yl]methyl}-2-methoxyphenoxy)acetamide

SMILES

CCc1noc(C2N(Cc(cc3)cc(OC)c3OCC(N)=O)CCC2)c1

InChI

InChI=1S/C19H25N3O4/c1-3-14-10-17(26-21-14)15-5-4-8-22(15)11-13-6-7-16(18(9-13)24-2)25-12-19(20)23/h6-7,9-10,15H,3-5,8,11-12H2,1-2H3,(H2,20,23)/t15-/m0/s1

InChI Key

DCLJXVQHDKIQRT-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD27215813

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

359.43

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.457

Distribution Coefficient, logD

-1.898

Water Solubility, LogSw

-2.07

Polar Surface Area

74.831

Acid Dissociation Constant (pKa)

15.51

Base Dissociation Constant (pKb)

10.76

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.40

J006-2630 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

CNS Targets (44014 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with J006-2630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J006-2630?
Check Price and Availability of J006-2630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J006-2630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J006-2630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J006-2630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J006-2630 available by request